|
ATE239907T1
(de)
|
1999-02-26 |
2003-05-15 |
Cellomics Inc |
Ein system für zellbasierte reihenuntersuchungen
|
|
WO2002038734A2
(en)
|
2000-11-13 |
2002-05-16 |
Cistem Molecular Corporation |
Methods for determining the biological effects of compounds on gene expression
|
|
US7981842B2
(en)
|
2001-06-08 |
2011-07-19 |
Panomics, Inc. |
Method for detecting transcription factor-protein interactions
|
|
JP4200100B2
(ja)
|
2001-11-07 |
2008-12-24 |
アジェンシス，インコーポレイテッド |
癌の処置および検出において有用な１６１ｐ２ｆ１０ｂと称される、核酸および対応タンパク質
|
|
US20170198046A1
(en)
|
2002-02-13 |
2017-07-13 |
Technion Research & Development Foundation Limited |
Compositions capable of specifically binding particular human antigen presenting molecule/ antigen complexes and uses thereof
|
|
WO2004029247A1
(en)
|
2002-09-26 |
2004-04-08 |
Centre For Translational Research In Cancer |
Nuclear receptor transcriptional corepressor and uses thereof
|
|
US20070178537A1
(en)
|
2003-06-30 |
2007-08-02 |
Sloan-Kettering Institute For Cancer Research |
Assays for detection of bioactive compounds that interact with heat shock protein 90
|
|
CN102989009B
(zh)
|
2003-12-31 |
2015-06-03 |
宾夕法尼亚州研究基金会 |
预测并克服对卵巢癌化疗的抗性的方法及预测结肠癌发生的方法
|
|
WO2005099745A2
(en)
|
2004-04-13 |
2005-10-27 |
Uab Research Foundation |
Gcp-170 fusion proteins and uses thereof
|
|
US20090143433A1
(en)
|
2004-12-01 |
2009-06-04 |
Curt Hendrix |
Cocktail for modulation of alzheimer's disease
|
|
WO2006063356A1
(en)
|
2004-12-10 |
2006-06-15 |
Isis Phamaceuticals, Inc. |
Regulation of epigenetic control of gene expression
|
|
WO2006070941A1
(ja)
|
2004-12-28 |
2006-07-06 |
Tokyo University Of Science |
蛍光分子プローブを用いた新規薬剤スクリーニング方法
|
|
US20070214509A1
(en)
|
2005-12-23 |
2007-09-13 |
The Parkinson's Institute |
Methods and systems for identifying compounds that modulate alpha-synuclein aggregation
|
|
CA2634821C
(en)
|
2005-12-23 |
2016-05-03 |
Andrew Emili |
Method for the identification of macromolecule targets of analytes
|
|
ES2338392B1
(es)
|
2006-08-18 |
2011-02-28 |
Universidad De Salamanca |
Metodo para la identificacion de signos de disfuncion neuronal pre-neurodegenerativos.
|
|
US9470683B2
(en)
|
2010-01-29 |
2016-10-18 |
Ge Healthcare Bio-Sciences Ab |
Method for determination of aggregates
|
|
US20130109737A1
(en)
|
2010-02-09 |
2013-05-02 |
Richard A. Young |
Mediator and cohesin connect gene expression and chromatin architecture
|
|
US8563705B2
(en)
|
2010-05-12 |
2013-10-22 |
Mayo Foundation For Medical Education And Research |
Ribonucleic acid binding motif protein 20 sequence variants
|
|
WO2012006551A2
(en)
|
2010-07-08 |
2012-01-12 |
The Brigham And Women's Hospital, Inc. |
Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules
|
|
EP2630154A1
(en)
|
2010-10-20 |
2013-08-28 |
F.Hoffmann-La Roche Ag |
Methods and compositions for modulating the wnt pathway
|
|
WO2012162249A1
(en)
|
2011-05-20 |
2012-11-29 |
Benjamin Wolozin |
Identification of compounds that disperse tdp-43 inclusions
|
|
US20140349938A1
(en)
|
2011-06-03 |
2014-11-27 |
President And Fellows Of Harvard College |
Methods of diagnosing and treating amyotrophic lateral sclerosis
|
|
EA201490230A1
(ru)
|
2011-07-08 |
2014-06-30 |
Слоан-Кеттеринг Инститьют Фор Кэнсер Рисерч |
Применение меченых ингибиторов hsp90
|
|
US20150045330A1
(en)
|
2012-01-17 |
2015-02-12 |
Kyoto University |
Prophylactic and therapeutic drug for amyotrophic lateral sclerosis and method of screening therefor
|
|
JP6340366B2
(ja)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
運動ニューロン疾患を診断および処置する方法
|
|
ES2762326T5
(es)
|
2012-10-15 |
2023-04-27 |
Ionis Pharmaceuticals Inc |
Métodos para modular la expresión de C9ORF72
|
|
EP2912178B1
(en)
|
2012-10-25 |
2020-06-17 |
Whitehead Institute For Biomedical Research |
Super-enhancers and methods of use thereof
|
|
HK1220233A1
(zh)
|
2013-03-15 |
2017-04-28 |
怀特黑德生物医学研究院 |
用於神经变性疾病的细胞性发现平台
|
|
KR101591265B1
(ko)
|
2014-03-28 |
2016-02-03 |
한남대학교 산학협력단 |
퇴행성 신경계 질환 치료제 스크리닝 방법
|
|
US20170233762A1
(en)
|
2014-09-29 |
2017-08-17 |
The Regents Of The University Of California |
Scaffold rnas
|
|
KR20170092543A
(ko)
|
2014-11-07 |
2017-08-11 |
톨레로 파마수티컬스, 인크. |
슈퍼-인핸서 부위에서 전사 조절을 표적화하는 방법
|
|
CA2966450A1
(en)
|
2014-12-17 |
2016-06-23 |
Olesya KHARENKO |
Inhibitors of bromodomains
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
WO2016105518A1
(en)
|
2014-12-23 |
2016-06-30 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
EP3242938B1
(en)
|
2015-01-09 |
2020-01-08 |
Bio-Rad Laboratories, Inc. |
Detection of genome editing
|
|
KR101671020B1
(ko)
|
2015-04-10 |
2016-11-02 |
충북대학교 산학협력단 |
2-메톡시-4-(3-(4-메톡시페닐)프로프-1-엔-1-일)페놀을 유효성분으로 하는 암의 치료용 약제학적 조성물
|
|
EP3362564B1
(en)
|
2015-10-14 |
2020-07-01 |
Aquinnah Pharmaceuticals, Inc. |
Nucleic acid based tia-1 inhibitors
|
|
GB201518477D0
(en)
*
|
2015-10-19 |
2015-12-02 |
Isis Innovation |
Biomolecule separation and modification
|
|
KR102346785B1
(ko)
|
2016-05-30 |
2022-01-04 |
막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. |
공동-분획에 의한 리간드 식별
|
|
US10533167B2
(en)
|
2016-06-09 |
2020-01-14 |
The Trustees Of Princeton University |
Optogenetic tool for rapid and reversible clustering of proteins
|
|
JP2019523242A
(ja)
|
2016-07-01 |
2019-08-22 |
アラーキス セラピューティクス， インコーポレイテッド |
Ｒｎａ機能をモジュレートするための化合物および方法
|
|
ES2973215T3
(es)
|
2016-09-02 |
2024-06-19 |
Univ Keio |
Agente terapéutico para la esclerosis lateral amiotrófica y composición para el tratamiento
|
|
JP2018050605A
(ja)
|
2016-09-30 |
2018-04-05 |
学校法人慶應義塾 |
筋萎縮性側索硬化症、及び前頭側頭型認知症の病態誘導人工合成遺伝子、及びこれを用いた病態モデル
|
|
US10303979B2
(en)
|
2016-11-16 |
2019-05-28 |
Phenomic Ai Inc. |
System and method for classifying and segmenting microscopy images with deep multiple instance learning
|
|
DK3565891T3
(da)
|
2017-01-09 |
2023-07-24 |
Whitehead Inst Biomedical Res |
Fremgangsmåder til ændring af genekspression ved forstyrrelse af transkriptionsfaktor-multimere, der strukturerer regulatoriske sløjfer
|
|
WO2018158160A1
(en)
|
2017-02-28 |
2018-09-07 |
Universitat Autonoma De Barcelona |
(nitro-phenyl)-nitropyridine compounds for treating synucleinopathies
|
|
US10538756B2
(en)
|
2017-03-06 |
2020-01-21 |
The Trustees Of Princeton University |
Disordered protein-based seeds for molecular clustering
|
|
WO2018170794A1
(en)
|
2017-03-22 |
2018-09-27 |
Tsinghua University |
Mutant fus model for als
|
|
US11492617B2
(en)
|
2017-08-08 |
2022-11-08 |
Ionis Pharmaceuticals, Inc |
Compositions and methods for modulation of protein aggregation
|
|
US10526380B2
(en)
|
2017-10-26 |
2020-01-07 |
St. Jude Children's Research Hospital |
Fusion protein and nucleic acid molecule for light-dependent stress granule assembly
|
|
WO2019109017A1
(en)
|
2017-12-01 |
2019-06-06 |
The Trustees Of Princeton University |
Light-responsive fusion proteins for controlling binding to targets
|
|
GB201803724D0
(en)
|
2018-03-08 |
2018-04-25 |
Cambridge Entpr Ltd |
Methods
|
|
CA3094974A1
(en)
|
2018-03-23 |
2019-09-26 |
Whitehead Institute For Biomedical Research |
Methods and assays for modulating gene transcription by modulating condensates
|
|
JP6624468B2
(ja)
|
2018-04-18 |
2019-12-25 |
国立大学法人滋賀医科大学 |
Ｔｄｐ−４３の凝集体が蓄積する疾患を治療及び／又は予防するための化合物のスクリーニング方法
|
|
US12521412B2
(en)
|
2018-08-16 |
2026-01-13 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Nucleic acids and nucleic acid analogs for treating, preventing, and disrupting pathological polynucleotide-binding protein inclusions
|
|
CN113196055B
(zh)
|
2018-10-15 |
2025-06-27 |
马克斯·普朗克科学促进协会 |
用于治疗疾病的化合物及其筛选方法
|
|
EP3921650A1
(en)
|
2019-02-08 |
2021-12-15 |
Dewpoint Therapeutics, Inc. |
Methods of characterizing condensate-associated characteristics of compounds and uses thereof
|
|
CA3140651A1
(en)
|
2019-05-15 |
2020-11-19 |
Whitehead Institute For Biomedical Research |
Methods of characterizing and utilizing agent-condensate interactions
|
|
CN114667451A
(zh)
|
2019-09-18 |
2022-06-24 |
露点治疗公司 |
用于鉴定调节与RBM20聚集体和/或Rbm20多肽相关的一种或多种特征的化合物的组合物、系统以及方法
|
|
CN114729941A
(zh)
|
2019-09-18 |
2022-07-08 |
露点治疗公司 |
筛选凝聚物相关特异性的方法及其用途
|
|
US20230314443A1
(en)
|
2020-08-12 |
2023-10-05 |
Dewpoint Therapeutics, Inc. |
Methods of identifying interactions of a compound and a condensate, or a component thereof, and uses thereof
|
|
WO2022187202A1
(en)
|
2021-03-02 |
2022-09-09 |
Dewpoint Therapeutics, Inc. |
New condensate paradigms
|
|
WO2022187225A1
(en)
|
2021-03-02 |
2022-09-09 |
Dewpoint Therapeutics, Inc. |
Methods of identifying a condensate phenotype and uses thereof
|
|
US20240375024A1
(en)
|
2021-08-20 |
2024-11-14 |
Dewpoint Therapeutics, Inc. |
Methods of isolating a composition comprising a target molecule
|
|
US20260043792A1
(en)
|
2022-08-03 |
2026-02-12 |
Dewpoint Therapeutics, Inc. |
Methods of identifying selective condensate modulators
|